XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Equity Instruments (Tables)
6 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of stock option activity
     Number of Options      Weighted Average Exercise Price      Weighted Average Remaining Contractual Life in Years  
Outstanding June 30, 2018     1,798     $ 325.97       6.95  
     Granted     -     $ -          
     Exercised     -     $ -          
     Forfeited/Cancelled     (11 )   $ 328.00          
Outstanding December 31, 2018     1,787     $ 325.96       6.49  
Exercisable at December 31, 2018     1,615     $ 325.74       6.39  
Schedule of restricted stock activity
     Number of Shares      Weighted Average Grant Date Fair Value      Weighted Average Remaining Contractual Life in Years  
                   
Unvested at June 30, 2018     37,200     $ 39.80       9.4  
Vested     (850 )   $ 40.40          
Granted     2,707,022     $ 1.30          
Cancelled     -     $ -          
Unvested at December 31, 2018     2,743,372     $ 1.81       9.6  
Schedule of stock-based compensation expense
     Three Months Ended December 31,      Six Months Ended December 31,  
Selling, general and administrative:   2018     2017     2018     2017  
                         
Stock options   $ 41,000     $ 81,000     $ 107,000     $ 276,000  
                                 
Restricted stock     153,000       32,000       239,000       104,000  
Total share-based compensation expense   $ 194,000     $ 113,000     $ 346,000     $ 380,000  
Schedule of all warrants
     Number of Warrants      Weighted Average Exercise Price      Weighted Average Remaining Contractual Life in Years  
Outstanding June 30, 2018     1,882,661     $ 25.94       4.61  
                         
Warrants issued in connection with the October 2018 offering     10,120,000     $ 1.50          
Warrants issued to underwriters in connection with the October 2018 offering     303,600     $ 1.50          
Outstanding December 31, 2018     12,306,261     $ 5.24       4.67  
Schedule of significant assumptions used in valuing options/warrants issued
    December 31, 2018     At Issuance  
Warrants:            
Volatility     166.2 %     188.0 %
Equivalent term (years)     3.63       5.00  
Exercise premium     5 %     20 %
Risk-free interest rate     2.48 %     1.83 %
Dividend yield     0.00 %     0.00 %